We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Rehabilitation for chronic neurological disorders including acquired brain injury Draft guidance consultation NICE guideline 20 May 2025 Pneumonia: diagnosis and management (update) Draft guidance ...

Eleven cutting-edge robotic surgery systems have been approved for use, potentially transforming care for thousands of NHS patients undergoing soft tissue and orthopaedic procedures.

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Olipudase alfa for treating acid sphingomyelinase deficiency (Niemann–Pick disease) type AB and type B HST32 2 April 2025 2 April 2025 Efanesoctocog alfa for treating and preventing bleeding episodes ...

For further information on our processes and methods, please see our quality standards process guide.

Hormone receptor (HR)-positive HER2-negative advanced breast cancer is incurable and the aim of treatment is to delay it getting worse and extend how long people live. If the cancer has alterations in ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

All NICE products on thyroid cancer. Includes any guidance.

Erdafitinib, also known as Balversa and made by Johnson & Johnson, is recommended in final draft guidance for adults with metastatic or unresectable FGFR-altered urothelial cancer who have previously ...